🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
The purpose of this research is to learn whether using teclistamab and talq...
Status
Not Yet Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2026-07-01
Trial ID
NCT07029776
To evaluate the outcome of a prednisolone and low dose methotrexate based p...
Status
Active Not Recruiting
Location
Prince of Wales Hospital
Start Date
2017-04-18
Trial ID
NCT03286634
This study is designed to confirm the efficacy, safety, and tolerability of...
Status
Completed
Location
University Hospital of Frankfurt (Main)
Start Date
2017-03-15
Trial ID
NCT03109093
Treatments Being Tested
This study was a multi-center, open-label, single-arm, Phase 2 study where ...
Status
Completed
Location
University of Chicago
Start Date
2017-07-10
Trial ID
NCT02969837
Treatments Being Tested
This study is to assess for Measurable Residual Disease (MRD) in multiple m...
Status
Active Not Recruiting
Location
University Of Chicago Medicine Comprehensive Cancer Center
Start Date
2019-10-30
Trial ID
NCT04108624
Treatments Being Tested
This trial will assess the feasibility of alpha/beta T-cell and B-cell depl...
Status
Recruiting
Location
Children's Hospital of Wisconsin
Start Date
2021-02-01
Trial ID
NCT04746209
Treatments Being Tested
This is a single-arm, open-label, multi-center phase I study using blinatum...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2022-02-18
Trial ID
NCT04604691
Treatments Being Tested